医学
间充质干细胞
磁共振成像
干细胞
荧光寿命成像显微镜
病理
临床前影像学
生物医学工程
分子成像
体内
核医学
作者
Chang Kyu Sung,Kyung Ah Hong,Shunmei Lin,Yuwon Lee,Jinmyung Cha,Jin-Kyu Lee,Cheolpyo Hong,Bong Soo Han,Sung Il Jung,Seung Hyup Kim,Kang Sup Yoon
标识
DOI:10.3348/kjr.2009.10.6.613
摘要
Objective: To determine the feasibility of labeling human mesenchymal stem cells (hMSCs) with bifunctional nanoparticles and assessing their potential as imaging probes in the monitoring of hMSC transplantation. Materials and Methods:The T1 and T2 relaxivities of the nanoparticles (MNP@SiO 2 [RITC]-PEG) were measured at 1.5T and 3T magnetic resonance scanner.Using hMSCs and the nanoparticles, labeling efficiency, toxicity, and proliferation were assessed.Confocal laser scanning microscopy and transmission electron microscopy were used to specify the intracellular localization of the endocytosed iron nanoparticles.We also observed in vitro and in vivo visualization of the labeled hMSCs with a 3T MR scanner and optical imaging.Results: MNP@SiO 2 (RITC)-PEG showed both superparamagnetic and fluorescent properties.The r 1 and r 2 relaxivity values of the MNP@SiO 2 (RITC)-PEG were 0.33 and 398 mM -1 s -1 at 1.5T, respectively, and 0.29 and 453 mM -1 s -1 at 3T, respectively.The effective internalization of MNP@SiO 2 (RITC)-PEG into hMSCs was observed by confocal laser scanning fluorescence microscopy.The transmission electron microscopy images showed that MNP@SiO 2 (RITC)-PEG was internalized into the cells and mainly resided in the cytoplasm.The viability and proliferation of MNP@SiO 2 (RITC)-PEG-labeled hMSCs were not significantly different from the control cells.MNP@SiO 2 (RITC)-PEG-labeled hMSCs were observed in vitro and in vivo with optical and MR imaging.Conclusion: MNP@SiO 2 (RITC)-PEG can be a useful contrast agent for stem cell imaging, which is suitable for a bimodal detection by MRI and optical imaging.ecent studies suggest that mesenchymal stem cells (MSCs) show significant potential as a novel cellular therapy for tissue regeneration (1).The development of new stem cell-based therapies requires a quantitative and qualitative assessment of stem cell distribution to the target organs, differentiation outcome, and engraftment (2, 3).In particular, the monitoring of cell trafficking in vivo and distinguishing whether cellular regeneration originated from an exogenous cell source is a key issue for developing successful stem cell therapies (4, 5).Although magnetic resonance imaging (MRI), radionuclide imaging, and optical imaging are all used to track the transplanted cells, MRI is progressing towards playing an important role in the development of stem cell therapy because its ability to demonstrate anatomic details with high contrast and exquisite spatial resolution, and can noninvasively follow stem cells for long periods of time (6, 7).The detection of the transplanted cells by MRI requires cells to be labeled magnetically either by endocytic internalizing or cell surface attachment of magnetic nanoparticles (MNPs) (8-11).Recently, a variety of magnetic nanoparticles such as superpara-
科研通智能强力驱动
Strongly Powered by AbleSci AI